Breaking News Instant updates and real-time market news.

GPRO

GoPro

$5.02

(0.00%)

, XLNX

Xilinx

$95.98

(0.00%)

09:40
09/30/19
09/30
09:40
09/30/19
09:40

Unusually active option classes on open September 30th

Unusual total active option classes on open include: GoPro (GPRO), Xilinx (XLNX), Costco (COST), Alibaba (BABA), SPDR S&P Biotech (XBI), and Wells Fargo (WFC).

GPRO

GoPro

$5.02

(0.00%)

XLNX

Xilinx

$95.98

(0.00%)

COST

Costco

$285.99

(0.00%)

BABA

Alibaba

$165.96

(0.00%)

XBI

SPDR S&P BIOTECH

$76.45

(0.00%)

WFC

Wells Fargo

$50.72

(0.00%)

  • 03

    Oct

  • 12

    Oct

  • 15

    Oct

  • 23

    Oct

  • 27

    Oct

GPRO GoPro
$5.02

(0.00%)

04/09/19
LBOW
04/09/19
NO CHANGE
LBOW
Neutral
GoPro checks point to results tracking towards guidance high-end, says Longbow
Longbow analyst Nikolay Todorov raised his first half sales and EPS forecasts for GoPro, stating that online indicators and his channel checks suggest that the company's camera mix is skewing towards HERO7 Black more than he expected. He believes revenue and EPS are tracking towards the high-end of GoPro's first half guidance, at least, and views consensus for 2Q sales and EPS as too low, Todorov tells investors. However, he keeps a Neutral rating on the stock, citing questions that remain regarding unit growth and a shrinking market over time.
05/10/19
JPMS
05/10/19
NO CHANGE
Target $8
JPMS
Neutral
JPMorgan says GoPro execution improving, boosts target to $8
JPMorgan analyst Paul Coster says GoPro's execution is improving with the company now a year into consistently meeting expectations, expanding gross margins and returning to sustainable profitability on a narrower product line-up. The analyst raised his price target for GoPro to $8 from $7.50 following the company's Q1 results but keeps a Neutral rating on the name. GoPro's growth "remains elusive," says Coster.
07/03/19
SBSH
07/03/19
NO CHANGE
SBSH
Spending trends favorable for Logitech, unfavorable for GoPro, says Citi
After surveying 75 retail and electronics stores in U.S. throughout June to inquire about promotions and sell-through, Citi analyst Asiya Merchant says spending trends are favorable for both Logitech (LOGI) and Corning (GLW) and unfavorable for GoPro (GPRO). Across categories, TVs stood out as the category most likely to be the top selling consumer electronics product and highest category to exceed sales expectations, while digital cameras are least likely to be a top seller and most likely to miss, Merchant tells investors in a research note. The analyst believes video gaming accessories trends are positive for Logitech while digital camera trends are negative for GoPro. The digital camera market is at historical lows, contends Merchant. The analyst keeps a Buy rating on Logitech shares with a $46 price target. She also lowered her price target for Neutral-rated iRobot (IRBT) to $95 from $100 to reflect the 25% tariff levied on robotic vacuums. Merchant adds that the survey yield "mixed" results for robotic vacuums.
07/10/19
LBOW
07/10/19
NO CHANGE
LBOW
Neutral
GoPro Q2 demand trends appear better than expected, says Longbow
Longbow analyst Nikolay Todorov said his checks with GoPro channel partners indicated that the initial curiosity and excitement around DJI's action camera was very short-lived and none of the partners saw an impact on GoPro's Q2 sales. The survey work, along with online indicators, suggest that HERO7 Black momentum remained strong and that Q2 demand trends were better than expected, said Todorov, who raised his estimates to the high end of GoPro's Q2 guidance but maintains a Neutral rating on the stock.
XLNX Xilinx
$95.98

(0.00%)

09/30/19
NOMU
09/30/19
NO CHANGE
NOMU
Nomura Instinet still cautious on semiconductors after Micron report
Micron Technology (MU) last week provided November quarter guidance for a 37% year-over-year decline in sales and a further drop in gross margin, to 25.5%, Nomura Instinet analyst David Wong tells investors in a research note titled "Little Evidence of Recovery Yet." Further, August global chip shipment data showed a continuing year-over-year decline in the mid- to high-teens range, adds the analyst. Wong remains cautious on the semiconductor and semiconductor equipment industry overall.
09/24/19
ARGS
09/24/19
NO CHANGE
Target $145
ARGS
Buy
Concerns about Xilinx CFO transition overdone, says Argus
Argus analyst Jim Kelleher kept his Buy rating and $145 price target on Xilinx, saying the 8% decline in its stock price on September 20th after the announcement of resignation of its CFO Lorenzo Flores was overdone. The analyst says the departure was not a termination for cause as Flores is leaving for a "more prestigious" job and expects the company to fill the role without a disruption. Kelleher remains positive on the "superior growth prospects" of Xilinx relative to its peers.
09/20/19
09/20/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Suzano (SUZ) downgraded to Neutral from Buy at Goldman Sachs with analyst Thiago Oje turning more cautious on the Latin America Pulp & Paper sector citing weaker demand stemming from U.S.-China trade tensions, "unprecedented" inventory levels that are 60% above historical averages, and "deteriorating" long-term outlooks after new capacity announcements. 2. Synovus (SNV) downgraded to In Line from Outperform at Evercore ISI. 3. Xilinx (XLNX) downgraded to Neutral from Buy at BofA/Merrill with analyst Vivek Arya citing the "sudden" departure of its CFO Lorenzo Flores last night for another firm. 4. Cosan (CZZ) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Javier Martinez de Olcoz Cerdan saying while he still sees a recovery in sugar prices ahead, Indian sugar may continue to pressure prices in the coming months. 5. Liberty Global (LBTYA) double downgraded to Sell from Buy at Citi with analyst Nayab Amjad saying the stock has outperformed since January on hopes of completion of the Swiss unit disposal, the closing of the Vodafone deal, and the recent tender offer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/19
MSCO
09/20/19
NO CHANGE
MSCO
Overweight
Morgan Stanley remains bullish longer-term on Xilinx despite near-term headwinds
Morgan Stanley analyst Joseph Moore said investor anxiety around near-term results at Xilinx will likely increase with CFO Lorenzo Flores leaving the company and no reiteration of forecasts being included in the associated press release. Moore sees September quarter results being in-line with consensus, but he is well below consensus with his December and March quarter estimates, he noted. However, he remains bullish on the stock longer-term and keeps an Overweight rating on the shares as he thinks drawing down wireless sets them up to grow across all segments, Moore tells investors.
COST Costco
$285.99

(0.00%)

09/19/19
09/19/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Costco (COST) downgraded to Underperform from Market Perform at Bernstein with analyst Brandon Fletcher saying "membership exhaustion" poses risks to the company's U.S. and international growth. 2. Bandwidth (BAND) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Meta Marshall saying the company is a good play on the growth of next-generation communications but its relative valuation versus peers "gives too much credit for platform depth." 3. Akamai (AKAM) downgraded to Sector Weight from Overweight at KeyBanc with analyst Brandon Nispel saying the downgrade is based on his view that accelerating growth for CDN in 2020 is built into expectations and the stock's valuation. 4. Hilton Grand Vacations (HGV) downgraded to Neutral from Buy at Goldman Sachs with analyst Stephen Grambling saying while leveraged buyout internal rate of returns could be attractive to $40 per share or higher, other names in the Lodging space offer better risk-adjusted returns. 5. U.S. Steel (X) downgraded to Underperform from Outperform at Macquarie with analyst David Lipschitz saying he expects steel prices to stay weak and the company's cash flow to be under pressure in a weak pricing environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/19
GDHS
09/20/19
UPGRADE
GDHS
Accumulate
Costco upgraded to Accumulate from Hold at Gordon Haskett
09/20/19
09/20/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Etsy (ETSY) upgraded to Outperform from Sector Perform at RBC Capital with analyst Shweta Khajuria saying she views the stock's risk/reward as attractive. 2. Herc Holdings (HRI) was double upgraded to Buy from Sell at Goldman Sachs while United Rentals (URI) was upgraded to Buy from Neutral. 3. Costco (COST) upgraded to Accumulate from Hold at Gordon Haskett with analyst Chuck Grom citing a meeting with CFO Richard Galanti that he called "bullish." 4. Aecom (ACM) upgraded to Buy from Hold at Argus with analyst John Staszak citing the company's transition to a "professional services business model," reducing its G&A costs by $225M by exiting from noncore markets, reducing its debt, and spinning off its management services division. 5. LiveRamp (RAMP) upgraded to Strong Buy from Outperform at First Analysis with analyst David Gearhart saying after hosting investor meetings with management, the analyst has greater appreciation for the company's offering and market position. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/19
GDHS
09/20/19
UPGRADE
Target $330
GDHS
Accumulate
Gordon Haskett ups Costco to Accumulate on 'immense' data mining opportunity
As previously reported, Gordon Haskett analyst Chuck Grom upgraded Costco to Accumulate from Hold following a meeting with CFO Richard Galanti that he called "bullish." His most important meeting takeaway was that Costco is "finally going down the personalization journey" to engage more with its customers. Costco has 97.2M card holders and a very loyal customer base, giving it an "immense" opportunity to mine data to predict and drive future purchases, said Grom. He also saw favorable results in recent survey work and thinks the company's Q4 EPS should beat consensus estimates "easily," Grom added. He raised his price target on Costco shares to $330 from $255.
BABA Alibaba
$165.96

(0.00%)

09/06/19
SBSH
09/06/19
NO CHANGE
Target $326
SBSH
Buy
NetEase price target raised to $326 from $301 at Citi
Citi analyst Hillman Chan raised his price target for NetEase (NTES) to $326 from $301 saying he's positive on the sale of Kaola to Alibaba (BABA). The disposal signals NetEase's continuous focus on profitability and the additional funding to Cloud Music could make it more competitive versus Tencent Music (TME), Chan tells investors in a research note. The analyst expects investors to gradually assign value to NetEase's remaining non-gaming assets, like Cloud Music, and he keeps a Buy rating on the shares.
09/10/19
BOFA
09/10/19
NO CHANGE
Target $39
BOFA
Buy
Easing competition presents potential upside for Pinduoduo, says BofA/Merrill
BofA Merrill Lynch analyst Joyce Ju said her proprietary price point checks on some products across Chinese e-commerce platforms, including Alibaba's (BABA) Taobao, support the assumption of a stabilized competitive landscape and less aggressive promotion in Q3. The easing price competition should give Pinduoduo (PDD) more budget flexibility and room for moderate margin upside in non-peak season, according to Ju, who raised her price target on the stock to $39 from $34. She maintains a Buy rating on Pinduoduo.
09/16/19
SBSH
09/16/19
NO CHANGE
Target $233
SBSH
Buy
Alibaba unlikely to revise sales guidance at investor day, says Citi
Citi analyst Alicia Yap expects Alibaba's September 23 and 24 investor days to focus on new chairman and CEO Daniel Zhang's vision and strategy, the CFO's comments on investment strategy and margins, and progress and customer feedback on recommended feeds and Tmall 2.0 initiatives. The analyst believes the CFO is unlikely to revise Alibaba's fiscal 2020 revenue guidance, and instead will likely offer reassurance on "healthy" growth in core marketplace margins and on a disciplined approach to new investment initiatives. Yap keeps a Buy rating on Alibaba shares with a $233 price target.
08/19/19
LEHM
08/19/19
INITIATION
Target $32
LEHM
Overweight
Pinduoduo initiated with an Overweight at Barclays
Barclays analyst Gregory Zhao initiated Pinduoduo (PDD) with an Overweight rating and $32 price target, noting that the company has been able to break through the Alibaba (BABA) and JD.com (JD) duopoly to accumulate a sizeable user base with its unique team-buy, social marketplace model. He expects upside in its ARPU and take rate during its expansion into the high-end market, Zhao noted.
XBI SPDR S&P BIOTECH
$76.45

(0.00%)

03/12/19
PIPR
03/12/19
NO CHANGE
PIPR
Biopharma stocks should be up sharply on Sharpless selection, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond said he expects biopharma stocks to be up sharply on news that former National Cancer Institute director Ned Sharpless will be named acting FDA commissioner. The biotech sector "experienced a swoon of sorts" since Scott Gottlieb announced his departure, but with the announcement of Gottlieb's favored choice as successor Raymond believes the FDA will remain "on its current industry-friendly and efficiency driven trajectory," the analyst tells investors.
WFC Wells Fargo
$50.72

(0.00%)

09/30/19
BARD
09/30/19
DOWNGRADE
Target $50
BARD
Neutral
Wells Fargo downgraded to Neutral from Outperform at Baird
Baird analyst David George downgraded Wells Fargo to Neutral from Outperform. The analyst likes the new CEO choice but the macro headwinds of slow growth and low rates are real, and improving the earnings run-rate and efficiency will take time. He noted the shares have a nice run over the past month and he would be a buyer in the mid-$40's. George lowered his price target to $50 from $52 on Wells Fargo shares.
09/30/19
ARGS
09/30/19
UPGRADE
Target $60
ARGS
Buy
Wells Fargo upgraded to Buy from Hold at Argus
Argus analyst Stephen Biggar upgraded Wells Fargo to Buy with a price target of $60 after the company named Charlie Scharf as its new CEO last week. The analyst is positive on Scharf's "impressive industry background" to improve Wells Fargo's financial performance, noting that he is a former protege of JPMorgan's Jamie Dimon. Biggar expects the new CEO to initially focus on addressing the company's regulatory issues which had stifled growth and working toward removal of the Federal Reserve's $2T asset cap imposed on the bank. The analyst adds that this removal should be a "strong catalyst" for Wells Fargo shares.
09/30/19
ARGS
09/30/19
UPGRADE
ARGS
Buy
Wells Fargo upgraded to Buy from Hold at Argus
09/30/19
MSCO
09/30/19
NO CHANGE
Target $50
MSCO
Equal Weight
Morgan Stanley ups Wells target to $50 after CEO hiring, but stays on sidelines
Morgan Stanley analyst Betsy Graseck said the hiring of Charlie Scharf to become CEO at Wells Fargo is a positive that lifts "a big uncertainty" and she raised her price target on the bank's shares to $50 from $47 following the news. However, she remains on the sidelines until there is more clarity on when the Fed imposed asset cap and consent order can be lifted, estimating that it has added about $2B to the bank's expense base. She also wonders if Scharf will pursue further business rationalization, which could reset earnings expectations going forward. Graseck keeps an Equal Weight rating on Wells Fargo shares, though she sees a path to a potential $56 stock price over the longer-term once the consent order gets lifted.

TODAY'S FREE FLY STORIES

EW

Edwards Lifesciences

$244.30

3.9 (1.62%)

13:39
11/15/19
11/15
13:39
11/15/19
13:39
Periodicals
Edwards recalling Pascal guide sheaths, Mass Device reports »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$132.78

1.8 (1.37%)

, LLY

Eli Lilly

$113.74

2.36 (2.12%)

13:19
11/15/19
11/15
13:19
11/15/19
13:19
Hot Stocks
Trump Administration announces 'historic' healthcare price transparency rules »

The Department of Health…

JNJ

Johnson & Johnson

$132.78

1.8 (1.37%)

LLY

Eli Lilly

$113.74

2.36 (2.12%)

MRK

Merck

$85.25

0.69 (0.82%)

PFE

Pfizer

$37.35

0.8 (2.19%)

SNY

Sanofi

$45.90

0.91 (2.02%)

AZN

AstraZeneca

$47.19

-0.18 (-0.38%)

GSK

GlaxoSmithKline

$43.93

0.08 (0.18%)

NVS

Novartis

$89.75

0.23 (0.26%)

RHHBY

Roche

$0.00

(0.00%)

BMY

Bristol-Myers

$58.56

0.06 (0.10%)

CI

Cigna

$190.19

0.52 (0.27%)

CNC

Centene

$54.98

0.32 (0.59%)

CVS

CVS Health

$73.41

0.48 (0.66%)

HUM

Humana

$323.19

5.24 (1.65%)

UNH

UnitedHealth

$258.89

3.13 (1.22%)

WCG

WellCare

$303.56

1.705 (0.56%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$126.41

4.11 (3.36%)

ANTM

Anthem

$282.36

0.32 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 07

    Dec

  • 09

    Dec

  • 10

    Dec

  • 13

    Dec

  • 21

    Jan

  • 24

    Jan

  • 24

    Jan

  • 30

    Jan

  • 05

    Feb

  • 06

    Feb

  • 14

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/15/19
11/15
13:17
11/15/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/15/19
11/15
13:16
11/15/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TORC

resTORbio

$1.04

-6.89 (-86.89%)

13:11
11/15/19
11/15
13:11
11/15/19
13:11
Downgrade
resTORbio rating change  »

resTORbio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEFA

iShares Core MSCI EAFE ETF

$64.11

0.36 (0.56%)

, QQQ

Invesco QQQ Trust

$202.59

1.17 (0.58%)

13:10
11/15/19
11/15
13:10
11/15/19
13:10
Technical Analysis
On The Fly: ETF fund flow highlights »

For the prior week ETF…

IEFA

iShares Core MSCI EAFE ETF

$64.11

0.36 (0.56%)

QQQ

Invesco QQQ Trust

$202.59

1.17 (0.58%)

SPLV

Powershares S&P 500 Low Volatility Portfolio

$57.30

0.01 (0.02%)

XLU

Utilities SPDR

$62.63

-0.04 (-0.06%)

XLF

Financial Select Sector

$29.74

0.1 (0.34%)

IVV

iShares Core S&P 500

$313.08

1.77 (0.57%)

SPY

SPDR S&P 500 ETF Trust

$311.30

1.77 (0.57%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$126.86

0.04 (0.03%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.93

0.245 (0.28%)

TLT

iShares 20+ Year Treasury Bond Fund

$137.86

-0.03 (-0.02%)

VCIT

Vanguard Intermediate-Term Corporate Bond Index Fund

$91.03

0.015 (0.02%)

SPIB

SPDR Portfolio Intermediate Term Corporate Bond ETF

$35.19

-0.02 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:06
11/15/19
11/15
13:06
11/15/19
13:06
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 11/15…

USO

United States Oil Fund

$12.11

0.2 (1.68%)

, BKR

Baker Hughes

$22.73

0.85 (3.88%)

13:03
11/15/19
11/15
13:03
11/15/19
13:03
General news
Baker Hughes reports U.S. rig count down 11 to 806 rigs »

Baker Hughes reports that…

USO

United States Oil Fund

$12.11

0.2 (1.68%)

BKR

Baker Hughes

$22.73

0.85 (3.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRA

Contura Energy

$8.73

-0.65 (-6.93%)

13:01
11/15/19
11/15
13:01
11/15/19
13:01
Hot Stocks
Contura Energy announces partial idling of Cumberland mine »

Contura Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDR

Cloudera

$8.79

0.25 (2.93%)

12:55
11/15/19
11/15
12:55
11/15/19
12:55
Options
Cloudera put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Dec

RHHBY

Roche

$0.00

(0.00%)

12:52
11/15/19
11/15
12:52
11/15/19
12:52
Hot Stocks
Roche to acquire Promedior in up to $1.4B deal »

Earlier, Promedior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

12:50
11/15/19
11/15
12:50
11/15/19
12:50
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.58

-0.89 (-1.96%)

12:49
11/15/19
11/15
12:49
11/15/19
12:49
Hot Stocks
Hulu + Live TV price to increase to $54.99 per month from $44.99 per month »

Hulu announced that it is…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.58

-0.89 (-1.96%)

DIS

Disney

$145.45

-1.74 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

12:45
11/15/19
11/15
12:45
11/15/19
12:45
General news
Breaking General news story  »

Week of 11/15…

BA

Boeing

$371.03

3.73 (1.02%)

, UAL

United Airlines

$92.97

0.43 (0.46%)

12:41
11/15/19
11/15
12:41
11/15/19
12:41
Hot Stocks
United Airlines pulls 737 Max jets off schedule until March 4 »

United Airlines (UAL) is…

BA

Boeing

$371.03

3.73 (1.02%)

UAL

United Airlines

$92.97

0.43 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APDN

Applied DNA Sciences

$4.50

-0.38 (-7.79%)

12:38
11/15/19
11/15
12:38
11/15/19
12:38
Hot Stocks
Empery Asset Management reports 7.17% passive stake in Applied DNA Sciences »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
11/15/19
11/15
12:35
11/15/19
12:35
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

TSLA

Tesla

$349.70

0.19 (0.05%)

, VWAGY

Volkswagen

$0.00

(0.00%)

12:25
11/15/19
11/15
12:25
11/15/19
12:25
Periodicals
VW CEO says company has no plans to cooperate with Tesla, Reuters reports »

Volkswagen (VWAGY) CEO…

TSLA

Tesla

$349.70

0.19 (0.05%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$5.17

0.03 (0.58%)

12:25
11/15/19
11/15
12:25
11/15/19
12:25
Options
Tailored Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NVDA

Nvidia

$206.25

-3.63 (-1.73%)

, AMZN

Amazon.com

$1,750.30

-4.41 (-0.25%)

12:23
11/15/19
11/15
12:23
11/15/19
12:23
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been higher…

NVDA

Nvidia

$206.25

-3.63 (-1.73%)

AMZN

Amazon.com

$1,750.30

-4.41 (-0.25%)

MSFT

Microsoft

$149.59

1.53 (1.03%)

UAA

Under Armour

$17.82

0.69 (4.03%)

UA

Under Armour

$16.04

0.48 (3.08%)

AMRN

Amarin

$22.89

1.4 (6.51%)

RH

RH

$188.04

12.85 (7.33%)

BRK.A

Berkshire Hathaway

$329,640.00

545 (0.17%)

BRK.B

Berkshire Hathaway

$219.62

0.26 (0.12%)

FTCH

Farfetch

$9.69

2.2 (29.37%)

AMAT

Applied Materials

$62.33

5.44 (9.56%)

ACB

Aurora Cannabis

$3.00

-0.29 (-8.81%)

OXY

Occidental Petroleum

$38.90

1.14 (3.02%)

TORC

resTORbio

$1.16

-6.77 (-85.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 28

    Dec

  • 06

    Jan

TORC

resTORbio

$1.14

-6.79 (-85.62%)

12:21
11/15/19
11/15
12:21
11/15/19
12:21
Downgrade
resTORbio rating change  »

resTORbio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

12:18
11/15/19
11/15
12:18
11/15/19
12:18
Periodicals
We Company facing SEC probe into possible rule breaches, Bloomberg says »

We Company's WeWork…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCBP

First Choice Bank

$22.49

-0.01 (-0.04%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Hot Stocks
First Choice Bancorp announces resignation of CFO Lynn Hopkins »

First Choice Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$120.92

-0.03 (-0.02%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Hot Stocks
AmEx reports October consumer card write-off rate 2.3% vs. 2.0% last month »

American Express reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/15/19
11/15
12:17
11/15/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.